Medical Weight Loss for Elmira, New York Residents
Elmira, New York residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Elmira through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Elmira Residents Choose New Hope Weight Loss
Elmira patients choose New Hope Weight Loss because a named physician, Dr. Anjmun Sharma, M.D., oversees every case, pricing is transparent (semaglutide from $166/month, tirzepatide from $233/month · just $7.70/day), and the entire program runs by telehealth from our Costa Mesa, California clinic, which has served over 5,400 patients across New York and beyond since 2020.
Elmira patients are cared for entirely through telehealth from our Costa Mesa, California clinic. There is no travel, your consultation with Dr. Sharma, prescription, and follow-ups all happen by secure video.
Elmira is served entirely by telehealth, so there is no local office to visit and no waiting room. We care for patients throughout downtown Elmira and the greater Chemung County area of the Southern Tier. Whether you are starting your first GLP-1 program or switching from a brand medication, your Elmira treatment plan is built around your health history and goals.
Like much of New York, many people in Elmira want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Elmira address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Elmira
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Elmira
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Elmira address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Elmira
How do I get treatment from Elmira?
As a Elmira, New York patient you connect with our Costa Mesa, California clinic by telehealth. Dr. Sharma oversees your plan by secure video and compounded medication ships to your home; eligibility is confirmed during the consultation.
Can I do this without an in-person visit from Elmira?
Yes, it is fully telehealth. Your review, prescription, and follow-up are remote, with medication shipped to Elmira in cold-pack packaging, no lines and no drive.
How much does it cost for Elmira patients?
A $119 physician review, then compounded semaglutide from $166/month or tirzepatide from $233/month (medication separate). HSA, FSA, Klarna, and Affirm are accepted, and there is never a distance surcharge.
What areas of Elmira do you serve?
We serve patients from across Elmira by telehealth, including downtown Elmira and the greater Chemung County area of the Southern Tier.
How is medication shipped to Elmira patients?
After Dr. Sharma approves your plan, compounded medication ships in discreet, temperature-appropriate packaging directly to your Elmira address from the identified 503(a) compounding pharmacy. Most patients receive it within days, with no pharmacy line and no drive.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Elmira, New York by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.